Preloader Close
e q u i l i b r i o b i o s c i e n c e s
Dawnload One Pager

About Us

SELTA

Staphylococcus Epidermidis LipoTeichoic Acid

about

Inducing Staphylococcus epidermidis (SE) Strain Isolated from the Microbiome of a Healthy Human Subject

  • LTA was initially discovered from a prostate secretion of a healthy human subject with no pelvic pain.
  • The commensal S. epidermidis (SE) strain was isolated, purified and characterized – and was shown to have beneficial anti-inflammatory and analgesic effects in mouse chronic pelvic pain models.
  • These beneficial effects of SE were shown to be mediated by SE LipoTeichoic Acid i.e., SELTA.
SELTA

An Immune Modulating Biologic from a Non-Pain
Inducing Staphylococcus epidermidis (SE) Strain Isolated from the Microbiome of a Healthy Human Subject

LTA was initially discovered from a prostate secretion of a healthy human subject with no pelvic pain.
The commensal S. epidermidis (SE) strain was isolated, purified and characterized – and was shown to have beneficial anti-inflammatory and analgesic effects in mouse chronic pelvic pain models.
These beneficial effects of SE were shown to be mediated by SE LipoTeichoic Acid i.e., SELTA.
Leadership Team
team 1

Dr. Praveen Thumbikat, DVM

Founder & Chief Scientific Officer

Lou Pascarella, MBA

Chief Executive Officer
te

David Arvan

Chief Business Officer